WallStreetZenWallStreetZen

NYSE: SNN
Smith & Nephew PLC Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SNN past earnings growth

How has SNN's earnings growth performed historically?
Company
40%
Industry
45.2%
Market
55.22%
SNN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SNN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
SNN's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

SNN past revenue growth

How has SNN's revenue growth performed historically?
Company
6.4%
Industry
10.51%
Market
17.62%
SNN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SNN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SNN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SNN earnings and revenue history

Current Revenue
$5.5B
Current Earnings
$263.0M
Current Profit Margin
4.7%
SNN's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

SNN Return on Equity

Current Company
5%
Current Industry
9.3%
Current Market
33.8%
SNN's Return on Equity (5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SNN announces earnings.

SNN Return on Assets

Current Company
2.6%
Current Industry
5.5%
SNN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SNN Return on Capital Employed

Current Company
4.81%
Current Industry
8.9%
SNN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SNN vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SNN$5.55B$1.11B$263.00M+2.50%-15.22%
PODD$1.87B$381.80M$395.30M+23.47%+81.10%
BRKR$3.12B$599.70M$352.10M+9.61%+14.77%
GMED$2.24B$292.84M$40.68M+24.67%-29.74%
ALGN$3.94B$813.73M$447.03M+12.49%+2.48%
View Top Medical Device Stocks

Smith & Nephew Earnings & Revenue FAQ

What were SNN's earnings last quarter?

On Invalid Date, Smith & Nephew (NYSE: SNN) reported Q2 2024 earnings per share (EPS) of N/A, up N/A year over year. Total Smith & Nephew earnings for the quarter were N/A. In the same quarter last year, Smith & Nephew's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Smith & Nephew stock.

What was SNN's earnings growth in the past year?

As of Q3 2024, Smith & Nephew's earnings has grown 40% year over year. This is 5.2 percentage points lower than the US Medical Devices industry earnings growth rate of 45.2%. Smith & Nephew's earnings in the past year totalled $263.00 million.

What was SNN's revenue last quarter?

On Invalid Date, Smith & Nephew (NYSE: SNN) reported Q2 2024 revenue of N/A up N/A year over year. In the same quarter last year, Smith & Nephew's revenue was N/A.

What was SNN's revenue growth in the past year?

As of Q3 2024, Smith & Nephew's revenue has grown 6.4% year over year. This is 4.11 percentage points lower than the US Medical Devices industry revenue growth rate of 10.51%. Smith & Nephew's revenue in the past year totalled $5.55 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.